TCL Archive Three Organizations Publish Guideline For Biomarker Testing for Targeted Therapies April 26, 2013
TCL Archive In Brief: Breast Cancer coalition Plan Rally, Conference; FDA Seeks Information On Unlabeled Drug Uses April 30, 1993
TCL Archive FDA Approves Gemzar For Ovarian Cancer, Contradicting ODAC Recommendation; Continues Agency Trend to Recognize Progression-Free Survival As An Endpoint. July 21, 2006
